Total Payments
$6,613
2024 Payments
$1,136
Companies
37
Transactions
456
Medicare Patients
1,970
Medicare Billing
$82,369
Payment Breakdown by Category
Food & Beverage$6,548 (99.0%)
Education$64.95 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,548 | 455 | 99.0% |
| Education | $64.95 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,662 | 141 | $0 (2024) |
| Novo Nordisk Inc | $990.72 | 65 | $0 (2024) |
| Lilly USA, LLC | $645.07 | 52 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $473.45 | 26 | $0 (2024) |
| Amgen Inc. | $324.98 | 16 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $258.79 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $222.07 | 16 | $0 (2024) |
| PFIZER INC. | $198.26 | 12 | $0 (2024) |
| Amarin Pharma Inc. | $193.07 | 10 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $173.61 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,136 | 77 | ABBVIE INC. ($395.25) |
| 2023 | $1,609 | 106 | ABBVIE INC. ($468.25) |
| 2022 | $2,164 | 153 | ABBVIE INC. ($452.47) |
| 2021 | $1,704 | 120 | AbbVie Inc. ($345.78) |
All Payment Transactions
456 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Obesity | ||||||
| 11/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.10 | General |
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | Axonics, Inc. | Bulkamid (Device), Axonics | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Urology | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: VACCINE | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.53 | General |
| 09/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.58 | General |
| 09/05/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,958 | 2,986 | $384,619 | $81,477 |
| 2022 | 1 | 12 | 12 | $2,838 | $891.66 |
Total Patients
1,970
Total Services
2,998
Medicare Billing
$82,369
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 288 | 538 | $129,168 | $37,681 | 29.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 145 | 145 | $30,951 | $14,805 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 160 | 221 | $35,431 | $10,250 | 28.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 253 | 443 | $9,746 | $3,671 | 37.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 206 | 278 | $89,516 | $2,846 | 3.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 219 | 305 | $14,030 | $2,291 | 16.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 153 | 176 | $23,232 | $2,283 | 9.8% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 14 | 14 | $2,730 | $1,957 | 71.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $3,751 | $1,154 | 30.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 30 | 30 | $8,923 | $857.82 | 9.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 48 | 50 | $6,550 | $823.00 | 12.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 50 | 74 | $4,676 | $607.51 | 13.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 162 | 212 | $4,664 | $462.00 | 9.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 56 | 59 | $5,074 | $405.05 | 8.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 30 | 38 | $2,850 | $315.02 | 11.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 13 | 13 | $1,105 | $245.96 | 22.3% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 44 | 51 | $1,581 | $213.18 | 13.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 41 | 290 | $5,800 | $212.70 | 3.7% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 12 | 13 | $2,041 | $180.70 | 8.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 12 | 13 | $1,534 | $114.92 | 7.5% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 12 | $1,265 | $102.96 | 8.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $2,838 | $891.66 | 31.4% |
About Keri Lowe, NP
Keri Lowe, NP is a Nurse Practitioner healthcare provider based in Muncie, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/30/2020. The National Provider Identifier (NPI) number assigned to this provider is 1609476456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Keri Lowe, NP has received a total of $6,613 in payments from pharmaceutical and medical device companies, with $1,136 received in 2024. These payments were reported across 456 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,548).
As a Medicare-enrolled provider, Lowe has provided services to 1,970 Medicare beneficiaries, totaling 2,998 services with total Medicare billing of $82,369. Data is available for 2 years (2022–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Registered Nurse
- Location Muncie, IN
- Active Since 10/30/2020
- Last Updated 05/11/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1609476456
Products in Payments
- VRAYLAR (Drug) $709.24
- FARXIGA (Drug) $375.91
- Wegovy (Drug) $312.39
- ELIQUIS (Drug) $311.20
- LINZESS (Drug) $284.70
- Ozempic (Drug) $225.59
- EMGALITY (Drug) $223.00
- TRULICITY (Drug) $222.25
- Kerendia (Drug) $222.07
- Otezla (Drug) $217.25
- UBRELVY (Drug) $216.84
- Rybelsus (Drug) $213.98
- Vascepa (Drug) $193.07
- ENTRESTO (Drug) $165.49
- MOUNJARO (Drug) $165.05
- NURTEC ODT (Drug) $164.53
- TRINTELLIX (Drug) $156.09
- QULIPTA (Drug) $155.13
- TRELEGY ELLIPTA (Drug) $149.45
- JARDIANCE (Drug) $137.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Muncie
Heather Hamilton, Np, NP
Nurse Practitioner — Payments: $8,333
Nurse Practitioner $8,333
Cayla Mays, Np, NP
Nurse Practitioner — Payments: $5,029
Nurse Practitioner $5,029
Pamela Carothers, Np, NP
Nurse Practitioner — Payments: $5,012
Nurse Practitioner $5,012
Michelle Hicks, N.p, N.P
Nurse Practitioner — Payments: $4,756
Nurse Practitioner $4,756
Amy Woebkenberg, Np, NP
Nurse Practitioner — Payments: $1,657
Nurse Practitioner $1,657
Daniella Stafford, Np, NP
Nurse Practitioner — Payments: $1,369
Nurse Practitioner $1,369